FR2781154B1 - Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques - Google Patents

Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Info

Publication number
FR2781154B1
FR2781154B1 FR9809059A FR9809059A FR2781154B1 FR 2781154 B1 FR2781154 B1 FR 2781154B1 FR 9809059 A FR9809059 A FR 9809059A FR 9809059 A FR9809059 A FR 9809059A FR 2781154 B1 FR2781154 B1 FR 2781154B1
Authority
FR
France
Prior art keywords
isoflavonoids
tumors
treatment
therapeutic composition
cytotoxic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9809059A
Other languages
English (en)
Other versions
FR2781154A1 (fr
Inventor
Francis Darro
Robert Kiss
Armand Frydman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9809059A priority Critical patent/FR2781154B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to JP2000559842A priority patent/JP2002520357A/ja
Priority to AU46282/99A priority patent/AU761417B2/en
Priority to IL14058099A priority patent/IL140580A0/xx
Priority to EA200100141A priority patent/EA200100141A1/ru
Priority to CNB998095478A priority patent/CN1139383C/zh
Priority to PCT/FR1999/001715 priority patent/WO2000003707A1/fr
Priority to EP99929481A priority patent/EP1096929A1/fr
Priority to KR1020017000477A priority patent/KR20020006510A/ko
Priority to BR9912817-9A priority patent/BR9912817A/pt
Priority to CA002337256A priority patent/CA2337256A1/fr
Publication of FR2781154A1 publication Critical patent/FR2781154A1/fr
Application granted granted Critical
Publication of FR2781154B1 publication Critical patent/FR2781154B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
FR9809059A 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques Expired - Fee Related FR2781154B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR9809059A FR2781154B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
KR1020017000477A KR20020006510A (ko) 1998-07-15 1999-07-13 세포독성물질을 이용한 종양의 치료에 사용되는플라보노이드류를 기초로한 치료 조성물
IL14058099A IL140580A0 (en) 1998-07-15 1999-07-13 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents
EA200100141A EA200100141A1 (ru) 1998-07-15 1999-07-13 Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами
CNB998095478A CN1139383C (zh) 1998-07-15 1999-07-13 用于借助细胞毒试剂治疗肿瘤过程的含异黄酮类的治疗组合物
PCT/FR1999/001715 WO2000003707A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base d'isoflavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
JP2000559842A JP2002520357A (ja) 1998-07-15 1999-07-13 細胞障害性因子を使用する腫瘍の処置において使用することを意図するイソフラノボイドをベースとする処置治療組成物
AU46282/99A AU761417B2 (en) 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
BR9912817-9A BR9912817A (pt) 1998-07-15 1999-07-13 Composição terapêutica à base de isoflavonóides destinada a ser utilizada no tratamento dos tumores por agentes citotóxicos
CA002337256A CA2337256A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
EP99929481A EP1096929A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base d'isoflavono des destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809059A FR2781154B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Publications (2)

Publication Number Publication Date
FR2781154A1 FR2781154A1 (fr) 2000-01-21
FR2781154B1 true FR2781154B1 (fr) 2001-09-07

Family

ID=9528649

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9809059A Expired - Fee Related FR2781154B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Country Status (11)

Country Link
EP (1) EP1096929A1 (fr)
JP (1) JP2002520357A (fr)
KR (1) KR20020006510A (fr)
CN (1) CN1139383C (fr)
AU (1) AU761417B2 (fr)
BR (1) BR9912817A (fr)
CA (1) CA2337256A1 (fr)
EA (1) EA200100141A1 (fr)
FR (1) FR2781154B1 (fr)
IL (1) IL140580A0 (fr)
WO (1) WO2000003707A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
EP1487434B1 (fr) * 2002-03-06 2007-05-09 The Medical Research and Education Trust Compositions d'extrait botanique ayant une action anticancereuse contenant du isoliquiritgenine
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
DE10337863A1 (de) * 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
CA2590048C (fr) 2007-05-23 2013-07-16 Institut National De La Recherche Scientifique Analogues de nucleoside de cytosine et isoflavones et leurs utilisations
CN106265669A (zh) * 2016-08-04 2017-01-04 大连理工大学 大豆苷元与10‑羟基喜树碱的药物组合及其应用
CN113842387A (zh) * 2021-11-19 2021-12-28 大连理工大学盘锦产业技术研究院 10-羟基喜树碱与鹰嘴豆芽素a的药物组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
GB9621757D0 (en) * 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions

Also Published As

Publication number Publication date
AU761417B2 (en) 2003-06-05
WO2000003707A1 (fr) 2000-01-27
IL140580A0 (en) 2002-02-10
CA2337256A1 (fr) 2000-01-27
CN1312712A (zh) 2001-09-12
CN1139383C (zh) 2004-02-25
FR2781154A1 (fr) 2000-01-21
JP2002520357A (ja) 2002-07-09
KR20020006510A (ko) 2002-01-19
EP1096929A1 (fr) 2001-05-09
BR9912817A (pt) 2001-05-08
AU4628299A (en) 2000-02-07
EA200100141A1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DE69532415D1 (de) Schmelzextrudierte oral verabreichbare opioidformulierungen
DE68912302D1 (de) Härtendes material für medizinischen und dentalen gebrauch.
FI973183A (fi) Diagnostiseen kuvantamiseen soveltuvia varjoaineita, joilla on pidentynyt viipymä veressä
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
FR2781154B1 (fr) Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
FR2781153B1 (fr) Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
DE58908633D1 (de) Patientenlagerungstisch mit in Richtung der Längsachse des Patientenlagerungstisches verstellbarer Lagerungsplatte.
ITRM910730A0 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" diradicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
ATE128862T1 (de) Zusammensetzung zur lokalen anwendung.
AU7793791A (en) Pharmaceutical composition for use in treating pain
FR2720944B1 (fr) Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie.
DE69000791D1 (de) Therapeutische mittel fuer metabolische knochenkrankheiten.
ITMI912224A1 (it) Impiego di composti adenosinici nel trattamento dell'ischemia
FR2744917B1 (fr) Composition therapeutique a base d'acetaminophene
FI953725A0 (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
DK0637956T3 (da) Anvendelse af remacemid til behandling af Parkinsonˆs sygdom
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
ZA947262B (en) Use of transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease
TH6324EX (th) อุปกรณ์สำหรับใช้ในการรักษาโรคเหงือก
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
KR960016358U (ko) 환자의 몸에 착탈가능하게 고정되는 링게르 걸이대
IT232830Y1 (it) unita' integrata mobile, per uso medicale e para-medicale,in paricolare per uso odontoiatrico.

Legal Events

Date Code Title Description
ST Notification of lapse